Aeglea aims to raise $60M for treating rare diseases – Austin Business Journal

Aeglea aims to raise $60M for treating rare diseases Austin Business Journal

Aeglea BioTherapeutics Inc., an Austin-based biotechnology company developing treatments for rare genetic diseases and cancer, plans to raise $60 million …